Trem2 H157Y increases soluble TREM2 production and reduces amyloid pathology.

Publication Year: 2023

DOI:
10.1186/s13024-023-00599-3

PMCID:
PMC9890893

PMID:
36721205

Journal Information

Full Title: Mol Neurodegener

Abbreviation: Mol Neurodegener

Country: Unknown

Publisher: Unknown

Language: N/A

Publication Details

Subject Category: Molecular Biology

Available in Europe PMC: Yes

Available in PMC: Yes

PDF Available: No

Transparency Score
4/6
66.7% Transparent
Transparency Indicators
Click on green indicators to view evidence text
Core Indicators
Evidence found in paper:

"bulk rna sequencing data are available in ncbi's gene expression omnibus with the accession number gse212618."

Code Sharing
Evidence found in paper:

"Declarations Ethics approval and consent to participateOur mice were housed in a temperature-controlled environment with a 12-h light–dark cycle and free access to food and water. All animal procedures were approved by the Mayo Clinic Institutional Animal Care and Use Committee (IACUC) and in accordance with the National Institutes of Health Guidelines for the Care and Use of Laboratory Animals. Consent for publicationAll authors have given their consent for publication. Competing interestsGB consults for SciNeuro and Vida Ventures, had consulted for AbbVie, E-Scape, and Eisai, and serves as a Co-Editor-in-Chief for Molecular Neurodegeneration. All other authors declare no competing interests. Competing interests GB consults for SciNeuro and Vida Ventures, had consulted for AbbVie, E-Scape, and Eisai, and serves as a Co-Editor-in-Chief for Molecular Neurodegeneration. All other authors declare no competing interests."

Evidence found in paper:

"This work was supported by NIH grants R01AG066395 (to G.B. and N.Z.), RF1AG056130, R37AG027924, and RF1AG046205 (to G.B)."

Protocol Registration
Open Access
Paper is freely available to read
Additional Indicators
Replication
Novelty Statement
Assessment Info

Tool: rtransparent

OST Version: N/A

Last Updated: Aug 05, 2025